Francesco Puleo

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Jean‐Luc Van Laethem · 9 shared papers, 2015–2022 · strength 0.80
   • Paper Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind. DOI 10.3390/cancers13061231↗
   • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
   • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
2. Rémy Nicolle · 7 shared papers, 2019–2022 · strength 0.76
   • Paper Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind. DOI 10.3390/cancers13061231↗
   • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
   • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
3. Jean‐Baptiste Bachet · 8 shared papers, 2015–2022 · strength 0.66
   • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
   • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
   • Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
4. Magali Svrcek · 6 shared papers, 2015–2022 · strength 0.55
   • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
   • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
   • Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
5. Jerome F. Cros · 6 shared papers, 2015–2022 · strength 0.55
   • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
   • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
   • Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
6. Tatjana Arsenijevic · 4 shared papers, 2021–2022 · strength 0.48
   • Paper Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind. DOI 10.3390/cancers13061231↗
   • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
   • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
7. Pascal R. Hammel · 5 shared papers, 2015–2022 · strength 0.47
   • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
   • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
   • Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
8. Raphaël Maréchal · 6 shared papers, 2015–2019 · strength 0.34
   • Paper hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. DOI 10.3390/cancers11111808↗
   • Paper Personalized medicine in pancreatic cancer: the revolution has begun. DOI 10.2217/pme.15.15↗
   • Paper DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. DOI 10.1038/bjc.2016.319↗
9. Pieter Demetter · 4 shared papers, 2015–2021 · strength 0.30
   • Paper Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind. DOI 10.3390/cancers13061231↗
   • Paper DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. DOI 10.1038/bjc.2016.319↗
   • Paper Feasibility of Immunohistochemistry on Endoscopic Ultrasound Fine-Needle Aspiration Samples for Evaluating Predictive B… DOI 10.1097/mpa.0000000000000672↗
10. Vinciane Rebours · 2 shared papers, 2021–2022 · strength 0.22
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
11. Julie Roques · 2 shared papers, 2021–2022 · strength 0.21
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
12. Laëtitia Dahan · 2 shared papers, 2021–2022 · strength 0.21
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
13. Odile Gayet · 2 shared papers, 2021–2022 · strength 0.21
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
14. Juan Iovanna · 2 shared papers, 2021–2022 · strength 0.21
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
15. Marc F. Giovannini · 2 shared papers, 2021–2022 · strength 0.21
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
16. Nelson Dusetti · 2 shared papers, 2021–2022 · strength 0.21
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
17. Jérôme Raffenne · 2 shared papers, 2019–2021 · strength 0.18
    • Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
    • Paper hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. DOI 10.3390/cancers11111808↗
18. Anne Couvelard Benveniste · 2 shared papers, 2019–2021 · strength 0.18
    • Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
    • Paper hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. DOI 10.3390/cancers11111808↗
19. Valérie Paradis · 2 shared papers, 2019–2021 · strength 0.18
    • Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
    • Paper hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. DOI 10.3390/cancers11111808↗
20. Nicky D’Haene · 1 shared paper, 2021 · strength 0.15
    • Paper Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind. DOI 10.3390/cancers13061231↗
21. Christelle Bouchart · 1 shared paper, 2021 · strength 0.15
    • Paper Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind. DOI 10.3390/cancers13061231↗
22. Marc Hilmi · 1 shared paper, 2021 · strength 0.12
    • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
23. Emmanuel Mitry · 1 shared paper, 2022 · strength 0.12
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
24. Brice Chanez · 1 shared paper, 2022 · strength 0.12
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
25. Sandrina Martens · 1 shared paper, 2019 · strength 0.11
    • Paper Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications. DOI 10.1093/annonc/mdz181↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.